William D. Leslie, MD, MSc; John T. Schousboe, MD, PhD
Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-3550.
Corresponding Author: William D. Leslie, MD, MSc, Department of Medicine (C5121), University of Manitoba, 409 Tache Avenue, Winnipeg, Manitoba R2H 2A6, Canada; e-mail, firstname.lastname@example.org.
Current Author Addresses: Dr. Leslie: Department of Medicine (C5121), University of Manitoba, 409 Tache Avenue, Winnipeg, Manitoba R2H 2A6, Canada.
Dr. Schousboe: HealthPartners Institute, 3311 Old Shakopee Road, Bloomington, MN 55425.
Leslie WD, Schousboe JT. Pharmacovigilance in the Real World. Ann Intern Med. 2019;170:201–202. [Epub ahead of print 1 January 2019]. doi: 10.7326/M18-3550
Download citation file:
Published: Ann Intern Med. 2019;170(3):201-202.
Published at www.annals.org on 1 January 2019
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use